Natalya Risinskaya

12PUBLICATIONS
30CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 13, 2025
Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma.

Maiia Soloveva, Maksim Solovev, Igor Yakutik

|Aug 14, 2025
PSG and Other Candidate Genes as Potential Biomarkers of Therapy Resistance in B-ALL: Insights from Chromosomal Microarray Analysis and Machine Learning.

Valeriya Surimova, Natalya Risinskaya, Ekaterina Kotova

|Jul 29, 2025
Missense Mutations in the KAT Domain of CREBBP Gene in Patients with Follicular Lymphoma: Implications for Differential Diagnosis and Prognosis.

Anna Smolianinova, Ivan Bolshakov, Yulia Sidorova

|Oct 16, 2024
Biallelic Loss of 7q34 (TRB) and 9p21.3 (CDKN2A/2B) in Adult Ph-Negative Acute T-Lymphoblastic Leukemia.

Natalya Risinskaya, Abdulpatakh Abdulpatakhov, Yulia Chabaeva

|Sep 14, 2024
Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma.

Maiia Soloveva, Maksim Solovev, Natalya Risinskaya

|Dec 23, 2023
DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.

Natalya Risinskaya, Maria Gladysheva, Abdulpatakh Abdulpatakhov

Pageof 2

Frequent Collaborators

9 joint publications

Andrey Sudarikov

5 joint publications

Yulia Chabaeva

4 joint publications

Tatiana Obukhova

3 joint publications

Yana Kozhevnikova